Cover Image
市場調查報告書

中樞神經系統醫藥品的全球市場:止痛藥·抗帕金森藥·麻醉劑·抗癲癇藥·其他

Central Nervous System Drugs Global Market Report 2018

出版商 The Business Research Company 商品編碼 531325
出版日期 內容資訊 英文 125 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中樞神經系統醫藥品的全球市場:止痛藥·抗帕金森藥·麻醉劑·抗癲癇藥·其他 Central Nervous System Drugs Global Market Report 2018
出版日期: 2018年02月01日 內容資訊: 英文 125 Pages
簡介

本報告提供全球中樞神經系統醫藥品的市場調查,提供市場定義和概要,市場的各種影響因素分析,各藥物部門·各地各國趨勢與市場規模的變化與預測,並彙整與宏觀經濟因素·醫療保健市場全體·各種產業指標的比較,競爭環境,企業簡介等資料。

第1章 市場特徵

第2章 市場規模·成長率

  • 市場成長:迄今的過程
    • 成長推進因素
    • 阻礙成長要素
  • 市場成長:預測
    • 成長推進因素
    • 阻礙成長要素

第3章 大環境分析

第4章 客戶資訊

第5章 中樞神經系統醫藥品市場分析:各種類

  • 全球市場的實際成果:各種類
    • 止痛藥
    • 抗帕金森藥
    • 麻醉劑
    • 抗癲癇藥
    • 其他
  • 全球市場的變化與預測:各種類
  • 市場趨勢·策略

第6章 中樞神經系統醫藥品市場分析:各地各國分析

  • 全球市場的實際成果:各地區
  • 全球市場的變化與預測:各地區
  • 市場實際成果:各國
  • 市場變化與預測:各國
  • 全球醫藥品市場實際成果:部門·各地區
  • 全球醫藥品市場實際成果:部門·各國

第7章 宏觀經濟因素與市場比較

  • 市場規模的佔 GDP的百分比
  • 平均每個人的平均支出額

第8章 宏觀經濟因素與市場比較:各國

  • 市場規模的佔 GDP的百分比:各國
  • 平均每個人的平均支出額:各國

第9章 產業指標與市場比較

  • 全球藥劑師數:各國
  • 市場收益 vs 藥劑師數:各國
  • 全球醫藥品公司數:各國
  • 市場收益 vs 醫藥品公司數:各國
  • 全球對R&D/產品開發的平均支出額:各國
  • 市場收益 vs 對R&D/產品開發的平均支出額:各國
  • 全球非專利&品牌銷售額的比例:各國
  • 市場收益 vs 非專利&品牌銷售額的比例:各國
  • 帕金森氏症的患病人數:各國
  • 全球精神科醫生數:各國
  • 市場收益 vs 精神科醫生數:各國
  • 全球一般開業醫生數:各國
  • 市場收益 vs 一般開業醫生數:各國

第10章 亞太地區市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 中國
  • 印度
  • 日本
  • 澳洲

第11章 西歐市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙

第12章 東歐市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 俄羅斯

第13章 北美市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 美國

第14章 南美市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 巴西

第15章 中東市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類

第16章 非洲市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類

第17章 競爭環境

  • 企業簡介
  • Pfizer Inc.
  • Biogen Idec
  • Novartis Ag
  • 大塚製藥
  • Teva 醫藥品

第18章 主要M&A:中樞神經系統醫藥品市場

第19章 市場背景:醫藥品市場

第20章 醫藥品產業的Financial Margins

第21章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Central Nervous System Drugs Market Global Report 2018 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global central nervous system drugs market.

Where is the largest and fastest growing market for the central nervous system drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The central nervous system drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider Healthcare market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The central nervous system drugs market section of the report gives context. It compares the central nervous system drugs market with other segments of the Healthcare market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Central Nervous System Drugs Indicators Comparison.

Scope:

Markets Covered: Other CNS drugs ; Anaesthetics; Analgesics; Anti-Parkinson drugs; Anti-Epileptics

Companies Mentioned: Biogen Inc,F. Hoffmann-La Roche Ltd,Johnson & Johnson,Pfizer Inc,Novartis AG

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Central Nervous System Drugs Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Reasons to Purchase:

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

1. Central Nervous System Drugs Market Characteristics

2. Central Nervous System Drugs Market Size And Growth

  • 2.1. Historic Market Growth, Value ($ Billion) and Volume (Million Units)
    • 2.1.1. Drivers Of The Market
    • 2.1.2. Restraints On The Market
  • 2.2. Forecast Market Growth, Value ($ Billion)
    • 2.2.1. Drivers Of The Market
    • 2.2.2. Restraints On The Market

3. Central Nervous System Drugs Trends And Strategies

4. Pestle Analysis

  • 4.1. Political
  • 4.2. Economic
  • 4.3. Social
  • 4.4. Technological
  • 4.5. Legal
  • 4.6. Environmental

5. Central Nervous System Drugs Market Customer Information

6. Central Nervous System Drugs Market Regional And Country Analysis

  • 6.1. Global Central Nervous System Drugs Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
  • 6.2. Global Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, By Region
  • 6.3. Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region
  • 6.4. Global Central Nervous System Drugs Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
  • 6.5. Global Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, By Country
  • 6.6. Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Country

7. Central Nervous System Drugs Market Segmentation

  • 7.1. Global Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Other CNS drugs

Anaesthetics

Analgesics

Anti-Parkinson drugs

Anti-Epileptics

  • 7.2. Global Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

8. Central Nervous System Drugs Market Segments

  • 8.1.Other CNS drugs

a) Market Characteristics

b) Market Trends & Strategies

c) Global Other CNS drugs Market, 2017, By Segment, Value ($ Billion)

  • 8.2.Anaesthetics

a) Market Characteristics

b) Market Trends & Strategies

c) Global Anaesthetics Market, 2017, By Segment, Value ($ Billion)

  • 8.3.Analgesics

a) Market Characteristics

b) Market Trends & Strategies

c) Global Analgesics Market, 2017, By Segment, Value ($ Billion)

  • 8.4.Anti-Parkinson drugs

a) Market Characteristics

b) Market Trends & Strategies

c) Global Anti-Parkinson drugs Market, 2017, By Segment, Value ($ Billion)

  • 8.5.Anti-Epileptics

a) Market Characteristics

b) Market Trends & Strategies

c) Global Anti-Epileptics Market, 2017, By Segment, Value ($ Billion)

9. Global Central Nervous System Drugs Market Comparison With Macro Economic Factors

  • 9.1. Central Nervous System Drugs Market Size, Percentage Of GDP, Global
  • 9.2. Per Capita Average Central Nervous System Drugs Expenditure, Global

10. Central Nervous System Drugs Market Comparison With Macro Economic Factors Across Countries

  • 10.1. Central Nervous System Drugs Market Size, Percentage Of GDP, By Country
  • 10.2. Per Capita Average Central Nervous System Drugs Expenditure, By Country

11. Central Nervous System Drugs Market Comparison With Industry Metrics

  • 11.1. Global Number Of Pharmacists, 2017, By Country
  • 11.2. Global Central Nervous System Market Revenue Versus Number Of Pharmacists, 2017, By Country
  • 11.3. Global Number Of Pharma Enterprises, 2017, By Country
  • 11.4. Global Central Nervous System Market Revenue Versus Number Of Pharma Enterprises, 2017, By Country
  • 11.5. Global Average Spending On R&D/Product Development, 2017, By Country
  • 11.6. Global Central Nervous System Market Revenue Versus Average Spending On R&D/Product Development, 2017, By Country
  • 11.7. Global Generic & Branded Sales Proportion By Country (Value), 2017, By Country
  • 11.8. Global Central Nervous System Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2017, By Country
  • 11.9. Prevalent Cases Of Parkinsons Disease, 2014, By Country
  • 11.10. Global Number Of Psychiatrists, 2017, By Country
  • 11.11. Global Central Nervous System Market Revenue Versus Number Of Psychiatrists, 2017, By Country
  • 11.12. Global Number Of General Practitioners 2017, By Country
  • 11.13. Global Central Nervous System Market Revenue Versus Number Of General Practitioners, 2017, By Country

12. Asia-Pacific Central Nervous System Drugs Market

    • 12.1.1. Asia-Pacific Central Nervous System Drugs Market Overview
    • 12.1.2. Asia-Pacific Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.1.3. Asia-Pacific Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.1.4. Asia-Pacific Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Other CNS drugs

Anaesthetics

Analgesics

Anti-Parkinson drugs

Anti-Epileptics

    • 12.1.5. Asia-Pacific Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.2. Asia-Pacific Central Nervous System Drugs Market: Country Analysis
  • 12.3. China Central Nervous System Drugs Market
    • 12.3.1. China Central Nervous System Drugs Market Overview
    • 12.3.2. China Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.3.3. China Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.3.4. China Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Other CNS drugs

Anaesthetics

Analgesics

Anti-Parkinson drugs

Anti-Epileptics

    • 12.3.5. China Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.4. India Central Nervous System Drugs Market
    • 12.4.1. India Central Nervous System Drugs Market Overview
    • 12.4.2. India Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.4.3. India Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.4.4. India Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Other CNS drugs

Anaesthetics

Analgesics

Anti-Parkinson drugs

Anti-Epileptics

    • 12.4.5. India Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.5. Japan Central Nervous System Drugs Market
    • 12.5.1. Japan Central Nervous System Drugs Market Overview
    • 12.5.2. Japan Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.5.3. Japan Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.5.4. Japan Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Other CNS drugs

Anaesthetics

Analgesics

Anti-Parkinson drugs

Anti-Epileptics

    • 12.5.5. Japan Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.6. Australia Central Nervous System Drugs Market
    • 12.6.1. Australia Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.6.2. Australia Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.6.3. Australia Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Other CNS drugs

Anaesthetics

Analgesics

Anti-Parkinson drugs

Anti-Epileptics

    • 12.6.4. Australia Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

13. Western Europe Central Nervous System Drugs Market

    • 13.1.1. Western Europe Central Nervous System Drugs Market Overview
    • 13.1.2. Western Europe Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.1.3. Western Europe Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.1.4. Western Europe Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Other CNS drugs

Anaesthetics

Analgesics

Anti-Parkinson drugs

Anti-Epileptics

    • 13.1.5. Western Europe Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.2. Western Europe Central Nervous System Drugs Market: Country Analysis
  • 13.3. UK Central Nervous System Drugs Market
    • 13.3.1. UK Central Nervous System Drugs Market Overview
    • 13.3.2. UK Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.3.3. UK Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.3.4. UK Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Other CNS drugs

Anaesthetics

Analgesics

Anti-Parkinson drugs

Anti-Epileptics

    • 13.3.5. UK Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.4. Germany Central Nervous System Drugs Market
    • 13.4.1. Germany Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.4.2. Germany Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.4.3. Germany Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Other CNS drugs

Anaesthetics

Analgesics

Anti-Parkinson drugs

Anti-Epileptics

    • 13.4.4. Germany Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.5 France Central Nervous System Drugs Market
    • 13.5.1 France Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.5.2 France Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.5.3. France Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Other CNS drugs

Anaesthetics

Analgesics

Anti-Parkinson drugs

Anti-Epileptics

    • 13.5.4. France Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.6. Italy Central Nervous System Drugs Market
    • 13.6.1. Italy Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.6.2. Italy Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.6.3. Italy Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Other CNS drugs

Anaesthetics

Analgesics

Anti-Parkinson drugs

Anti-Epileptics

    • 13.6.4. Italy Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.7. Spain Central Nervous System Drugs Market
    • 13.7.1. Spain Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.7.2. Spain Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.7.3. Spain Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Other CNS drugs

Anaesthetics

Analgesics

Anti-Parkinson drugs

Anti-Epileptics

    • 13.7.4. Spain Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

14. Eastern Europe Central Nervous System Drugs Market

    • 14.1.1. Eastern Europe Central Nervous System Drugs Market Overview
    • 14.1.2. Eastern Europe Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 14.1.3. Eastern Europe Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 14.1.4. Eastern Europe Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Other CNS drugs

Anaesthetics

Analgesics

Anti-Parkinson drugs

Anti-Epileptics

    • 14.1.5. Eastern Europe Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 14.2. Eastern Europe Central Nervous System Drugs Market: Country Analysis
  • 14.3. Russia Central Nervous System Drugs Market
    • 14.3.1. Russia Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 14.3.2. Russia Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 14.3.3. Russia Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Other CNS drugs

Anaesthetics

Analgesics

Anti-Parkinson drugs

Anti-Epileptics

    • 14.3.4. Russia Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

15. North America Central Nervous System Drugs Market

    • 15.1.1. North America Central Nervous System Drugs Market Overview
    • 15.1.2. North America Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 15.1.3. North America Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 15.1.4. North America Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Other CNS drugs

Anaesthetics

Analgesics

Anti-Parkinson drugs

Anti-Epileptics

    • 15.1.5. North America Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 15.2. North America Central Nervous System Drugs Market: Country Analysis
  • 15.3. USA Central Nervous System Drugs Market
    • 15.3.1. USA Central Nervous System Drugs Market Overview
    • 15.3.2. USA Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 15.3.3. USA Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 15.3.4. USA Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Other CNS drugs

Anaesthetics

Analgesics

Anti-Parkinson drugs

Anti-Epileptics

    • 15.3.5. USA Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

16. South America Central Nervous System Drugs Market

    • 16.1.1. South America Central Nervous System Drugs Market Overview
    • 16.1.2. South America Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 16.1.3. South America Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 16.1.4. South America Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Other CNS drugs

Anaesthetics

Analgesics

Anti-Parkinson drugs

Anti-Epileptics

    • 16.1.5. South America Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 16.2. South America Central Nervous System Drugs Market: Country Analysis
  • 16.3. Brazil Central Nervous System Drugs Market
    • 16.3.1. Brazil Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 16.3.2. Brazil Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 16.3.3. Brazil Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Other CNS drugs

Anaesthetics

Analgesics

Anti-Parkinson drugs

Anti-Epileptics

    • 16.3.4. Brazil Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

17. Middle East Central Nervous System Drugs Market

    • 17.1.1. Middle East Central Nervous System Drugs Market Overview
    • 17.1.2. Middle East Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 17.1.3. Middle East Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 17.1.4. Middle East Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Other CNS drugs

Anaesthetics

Analgesics

Anti-Parkinson drugs

Anti-Epileptics

    • 17.1.5. Middle East Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

18. Africa Central Nervous System Drugs Market

    • 18.1.1. Africa Central Nervous System Drugs Market Overview
    • 18.1.2. Africa Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 18.1.3. Africa Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 18.1.4. Africa Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Other CNS drugs

Anaesthetics

Analgesics

Anti-Parkinson drugs

Anti-Epileptics

    • 18.1.5. Africa Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

19. Central Nervous System Drugs Market Competitive Landscape

  • 19.1. Company Profiles
  • 19.2. Biogen Inc
    • 19.2.1. Overview
    • 19.2.2. Products And Services
    • 19.2.3. Strategy
    • 19.2.4. Financial Performance
  • 19.3. F. Hoffmann-La Roche Ltd
    • 19.3.1. Overview
    • 19.3.2. Products And Services
    • 19.3.3. Strategy
    • 19.3.4. Financial Performance
  • 19.4. Johnson & Johnson
    • 19.4.1. Overview
    • 19.4.2. Products And Services
    • 19.4.3. Strategy
    • 19.4.4. Financial Performance
  • 19.5. Pfizer Inc
    • 19.5.1. Overview
    • 19.5.2. Products And Services
    • 19.5.3. Strategy
    • 19.5.4. Financial Performance
  • 19.6. Novartis AG
    • 19.6.1. Overview
    • 19.6.2. Products And Services
    • 19.6.3. Strategy
    • 19.6.4. Financial Performance

20. Key Mergers And Acquisitions In The Central Nervous System Drugs Market

21. Market Background: Central Nervous System Drugs Market

    • 21.1.1. Central Nervous System Drugs Market Characteristics
    • 21.1.2. Central Nervous System Drugs Market Historic Growth, Value ($ Billion)
      • 21.1.2.1. Drivers Of The Market
      • 21.1.2.2. Restraints Of The Market
    • 21.1.3. Central Nervous System Drugs Market Forecast Growth, Value ($ Billion)
      • 21.1.3.1. Drivers Of The Market
      • 21.1.3.2. Restraints Of The Market
    • 21.1.4. Central Nervous System Drugs Trends And Strategies
  • 21.2. Central Nervous System Drugs Market Regional And Country Analysis
    • 21.2.1. Global Central Nervous System Drugs Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
    • 21.2.2. Global Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, By Region
    • 21.2.3. Central Nervous System Drugs Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
    • 21.2.4. Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, By Country
    • 21.2.5. Central Nervous System Drugs Market, Growth And Market Share Comparison, By Segment
    • 21.2.6. Central Nervous System Drugs Market, Growth And Market Share Comparison, By Country And Segment
  • 21.3. Global Central Nervous System Drugs Market Comparison With Macro Economic Factors
    • 21.3.1. Central Nervous System Drugs Market Size, Percentage Of GDP, Global
    • 21.3.2. Per Capita Average Central Nervous System Drugs Expenditure, Global
  • 21.4. Central Nervous System Drugs Market Comparison With Macro Economic Factors Across Countries
    • 21.4.1. Central Nervous System Drugs Market Size, Percentage Of GDP, By Country
    • 21.4.2. Per Capita Average Central Nervous System Drugs Expenditure, By Country
  • 21.5. Key Mergers And Acquisitions In The Central Nervous System Drugs Market

22. Appendix

  • 22.1. NAICS Definitions Of Industry Covered In This Report
  • 22.2. Abbreviations
  • 22.3. Currencies
  • 22.4. Research Inquiries
  • 22.5. The Business Research Company
  • 22.6. Copyright And Disclaimer
Back to Top